Amit Sachdev - 24 Feb 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Chief Patient Officer
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
24 Feb 2022
Net transactions value
-$1,678,872
Form type
4
Filing time
28 Feb 2022, 16:25:57 UTC
Previous filing
22 Feb 2022
Next filing
11 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $1,678,872 -7,368 -13% $227.86 48,210 24 Feb 2022 Direct
holding VRTX Common Stock 882 24 Feb 2022 401(k)
holding VRTX Common Stock 15,573 24 Feb 2022 Held in Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.